-
Hold Alembic Pharma: target of Rs 885: ICICI Direct
ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 885 in its research report dated July 27, 2021.
-
Dr Reddy’s: Growth story remains intact; margins key monitorable
Dr Reddy's margins are likely to be weighed by recurring investments - digitization, brand building exercise & elevated R&D - in near to medium term
-
Accumulate Alembic Pharmaceuticals; target of Rs 995: KR Choksey
KR Choksey recommended Accumulate rating on Alembic Pharmaceuticals with a target price of Rs 995 in its research report dated May 08, 2021.
-
Hold Alembic Pharma: target of Rs 1055: ICICI Direct
ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 1055 in its research report dated May 05, 2021.
-
Neutral Alembic Pharma; target of Rs 1070: Motilal Oswal
Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 1070 in its research report dated January 19, 2021.
-
Hold Alembic Pharma; target of Rs 1055: ICICI Direct
ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 1055 in its research report dated January 20, 2021.
-
Buy Alembic Pharmaceuticals; target of Rs 1286 KR Choksey
KR Choksey is bullish on Alembic Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1286 in its research report dated October 26, 2020.
-
Buy Alembic Pharma; target of Rs 1170: ICICI Direct
ICICI Direct is bullish on Alembic Pharma recommended buy rating on the stock with a target price of Rs 1170 in its research report dated October 23, 2020.
-
Buy Alembic Pharma; target of Rs 1180: YES Securities
YES Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1180 in its research report dated October 22, 2020.
-
Buy Alembic Pharma; target of Rs 1140: ICICI Direct
ICICI Direct is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1140 in its research report dated July 23, 2020.
-
Buy Alembic Pharma; target of Rs 1180: YES Securities
YES Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1180 in its research report dated July 22, 2020.
-
Neutral Alembic Pharma; target of Rs 1122: Motilal Oswal
Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 1122 in its research report dated July 22, 2020.
-
Neutral Alembic Pharmaceuticals; target of Rs 975: Motilal Oswal
Motilal Oswal recommended Neutral rating on Alembic Pharmaceuticals with a target price of Rs 975 in its research report dated July 05, 2020.
-
Buy Alembic Pharma; target of Rs 1100: YES Securities
YES Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated June 15, 2020.
-
Buy Alembic Pharma; target of Rs 1100: YES Securities
YES Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated May 19, 2020.
-
India Inc’s profits to suffer hard knock from inventory losses – Part I
-
Hold Alembic Pharma; target of Rs 540: ICICI Direct
ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 540 in its research report dated July 30, 2019.
-
Hold Alembic Pharma; target of Rs 560: ICICI Direct
ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 560 in its research report dated May 09, 2019.
-
Hold Alembic Pharma; target of Rs 620: ICICI Direct
ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 620 in its research report dated January 23, 2019.
-
Hold Alembic Pharma; target of Rs 560: ICICI Direct
ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 560 in its research report dated October 23, 2018.
-
Hold Alembic Pharma; target of Rs 525: ICICI Direct
ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 525 in its research report dated July 30, 2018.
-
Hold Alembic Pharma; target of Rs 460: ICICI Direct
ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 460 in its research report dated May 17, 2018.
-
Hold Alembic Pharma; target of Rs 530: ICICI Direct
ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 530 in its research report dated November 09, 2017.
-
Hold Alembic Pharma; target of Rs 580: KR Choksey
KR Choksey recommended hold rating on Alembic Pharma with a target price of Rs 580 in its research report dated July 21, 2017.
-
Hold Alembic Pharma; target of Rs 570: ICICI Direct
ICICI Direct has recommended hold rating on Alembic Pharma with a target price of Rs 570 in its research report dated July 21, 2017.
